Rosemary Zuna to Disease-Free Survival
                            
                            
                                This is a "connection" page, showing publications Rosemary Zuna has written about Disease-Free Survival.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.051
         
        
        
     
 
    
        
        - 
            A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol. 2014 Jun; 133(3):537-41.
            
            
                Score: 0.026
             
- 
            The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):377-82.
            
            
                Score: 0.025